50742 Federal Register / Vol. 76, No. 158 / Tuesday, August 16, 2011 / Notices 

Internet, go to PDA’s Web site: http:// 

www.pda.org/pdafda2011. 

The registrar will also accept payment 

by major credit cards (VISA/American 

Express/MasterCard only). For more 

information on the meeting, or for 

questions on registration, contact PDA 

(see Contact). 

Transcripts: As soon as a transcript is 

available, it can be obtained in either 

hardcopy or on CD–ROM, after 

submission of a Freedom of Information 

request. Written requests are to be sent 

to Division of Freedom of Information 

(ELEM–1029), Food and Drug 

Administration, 12420 Parklawn Dr., 

Element Bldg., Rockville, MD 20857. 

SUPPLEMENTARY INFORMATION: The PDA/ 

FDA joint public conference offers the 

unique opportunity for participants to 

join FDA representatives and industry 

experts in face-to-face dialogues. Each 

year, FDA speakers provide updates on 

current efforts affecting the 

development of global regulatory 

strategies, while industry professionals 

from some of today’s leading 

pharmaceutical companies present case 

studies on how they employ global 

strategies in their daily processes. 

Through a series of sessions and 

meetings, the conference will provide 

participants with the opportunity to 

hear directly from FDA experts and 

representatives of global regulatory 

authorities on best practices, including: 

• Accountability in a Global 

Environment—Enforcement and Supply 

Chain 

• Office of International Programs 101 

& Foreign Inspections 

• International Conference on 

Harmonization Q11 

• New Regulations—Status Update 

• First Cycle Review 

• Drug Safety 

• Good Inspection Practices— 

Domestic 

• Process Validation 

• Emerging Regulations for Positron 

Emission Tomography 

• FDA/Pharmaceutical Inspection Cooperation Scheme 

• Standards 

• International Compliance Update 

• Good Manufacturing Practice Life 

Cycle 

• Supply Chain 

To help ensure the quality of FDAregulated products, the workshop helps 

to achieve objectives set forth in section 

406 of the FDA Modernization Act of 

1997 (21 U.S.C. 393) which includes 

working closely with stakeholders and 

maximizing the availability and clarity 

of information to stakeholders and the 

public. The workshop also is consistent 

with the Small Business Regulatory 

Enforcement Fairness Act of 1996 (Pub. 

L. 104–121), as outreach activities by 

Government Agencies to small 

businesses. 

Dated: August 11, 2011. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2011–20791 Filed 8–15–11; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Cardiovascular Sciences 

Dates: September 9, 2011 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Yuanna Cheng, MD, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

MSC 7814, Bethesda, MD 20892, (301)435– 

1195, Chengy5@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Social 

Science and Population Studies: Second 

Panel. 

Dates: September 19, 2011. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Suzanne Ryan, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3139, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

1712, ryansj@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 9, 2011. 

Anna P. Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–20829 Filed 8–15–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

T35 Training Grant in Pediatric Respiratory, 

Sleep, and Transfusion Medicine. 

Date: September 7, 2011. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Stephanie L Constant, 

PhD, Scientific Review Officer, Office of 

Scientific Review/DERA, National Heart, 

Lung, and Blood Institute, 6701 Rockledge 

Drive, Room 7189, Bethesda, MD 20892, 301– 

443–8784, constantsl@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: August 10, 2011. 

Anna P. Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–20845 Filed 8–15–11; 8:45 am] 

BILLING CODE 4140–01–P 


emcdonald on DSK2BSOYB1PROD with NOTICES